Juan M. Farina

ORCID: 0000-0002-5824-8485
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Pectus Deformity Diagnosis and Treatment
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Mosquito-borne diseases and control
  • Pulmonary Hypertension Research and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Lipoproteins and Cardiovascular Health
  • Parasites and Host Interactions
  • Trauma Management and Diagnosis
  • Trypanosoma species research and implications
  • Cardiomyopathy and Myosin Studies
  • Transplantation: Methods and Outcomes
  • Coronary Interventions and Diagnostics
  • Business, Education, Mathematics Research
  • Cardiovascular Effects of Exercise
  • Congenital Heart Disease Studies
  • Parasitic Diseases Research and Treatment
  • Cardiac Structural Anomalies and Repair
  • Viral Infections and Vectors
  • Reconstructive Surgery and Microvascular Techniques
  • Cardiac electrophysiology and arrhythmias
  • Cardiac pacing and defibrillation studies
  • Viral Infections and Immunology Research
  • Vector-borne infectious diseases

Mayo Clinic Hospital
2021-2025

WinnMed
2021-2025

Mayo Clinic in Florida
2021-2025

Mayo Clinic in Arizona
2022-2025

Hospital Italiano de Buenos Aires
2018-2024

Kingston Health Sciences Centre
2023

Phoenix (United States)
2023

Mayo Clinic
2023

Queen's University
2023

Hospital General Universitario Gregorio Marañón
2021

Background Pectus excavatum is the most common chest wall deformity. There still controversy about cardiopulmonary limitations of this disease and benefits surgical repair. This study evaluates impact pectus on function adult patients before after a modified minimally invasive Methods Results In retrospective cohort study, an electronic database was used to identify consecutive (aged ≥18 years) who underwent exercise testing primary repair at Mayo Clinic Arizona from 2011 2020. total, 392...

10.1161/jaha.121.022149 article EN cc-by-nc-nd Journal of the American Heart Association 2022-04-04

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy. It follows an autosomal dominant inheritance pattern in cases, with incomplete penetrance and heterogeneity. familial 60% of cases these are caused by pathogenic variants core sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1). Genetic testing using targeted disease-specific panels that utilize next-generation sequencing (NGS) include strongest evidence association syndrome-associated highly...

10.3390/biomedicines12030682 article EN cc-by Biomedicines 2024-03-19

<strong>Introduction:</strong> Neglected tropical diseases (NTDs) are a group of infections that prevalent in many the and sub-tropical developing countries where poverty is rampant. NTDs have remained largely unnoticed global health agenda. There substantial gap between burden disease for cardiovascular (CVD) research devoted to affected populations. We created Latin-American initiative with emerging leaders (EL) from Interamerican Society Cardiology (IASC) objective perform multiple...

10.5334/gh.867 article EN cc-by Global Heart 2020-01-01

Abstract Aims Lipoprotein(a) [Lp(a)] has demonstrated its association with atherosclerosis and myocardial infarction. However, role in the development of in-stent restenosis (ISR) after percutaneous coronary intervention (PCI) is not clearly established. The aim this study to investigate between Lp(a) ISR. Methods results A retrospective adult patients who underwent successful PCI January 2006 December 2017 at three Mayo Clinic sites had a preprocedural measurement was conducted. Patients...

10.1093/eurjpc/zwae212 article EN European Journal of Preventive Cardiology 2024-06-24

Abstract Aims Cardiac amyloidosis (CA) is common in patients with severe aortic stenosis (AS) undergoing transcatheter valve replacement (TAVR). has poor outcomes, and its assessment all TAVR costly challenging. Electrocardiogram (ECG) artificial intelligence (AI) algorithms that screen for CA may be useful to identify at-risk patients. Methods results In this retrospective analysis of our institutional National Cardiovascular Disease Registry (NCDR)-TAVR database, between January 2012...

10.1093/ehjdh/ztae022 article EN cc-by European Heart Journal - Digital Health 2024-03-13

Systemic vasculitides are a rare and complex group of diseases that can affect multiple organ systems. Clinically, presentation may be vague non-specific as such, diagnosis subsequent management challenging. These entities typically classified by the size vessel involved, including large-vessel vasculitis (giant cell arteritis, Takayasu's clinically isolated aortitis), medium-vessel (including polyarteritis nodosa Kawasaki disease), small-vessel (granulomatosis with polyangiitis eosinophilic...

10.3390/diagnostics14080838 article EN cc-by Diagnostics 2024-04-18

Abstract Background The prognosis in patients with advanced cardiac amyloidosis (CA) remains poor. Objectives We sought to describe survival post heart transplantation (HT) amyloid compared non‐amyloid recipients, highlight waitlist times within the new allocation system across three Organ Procurement and Transplantation Network (OPTN) regions, multiorgan (MOT) hereditary amyloidosis. Methods This is a retrospective review of end‐stage CA who underwent HT at Mayo Clinic from January 2007...

10.1111/ctr.70070 article EN Clinical Transplantation 2025-01-01

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although lipoprotein(a) [Lp(a)] known to be a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD), its role in development of AF, independent this association, remains unclear. Adult patients from three Mayo Clinic sites with baseline Lp(a) and without AF history were included. Patients categorized into two groups based on their levels: high (≥50 mg/dL) low (<50 mg/dL). Survival probabilities free...

10.1093/eurjpc/zwaf063 article EN other-oa European Journal of Preventive Cardiology 2025-02-07

10.1016/j.athoracsur.2025.01.030 article EN The Annals of Thoracic Surgery 2025-02-01
Coming Soon ...